Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Pfizer (Perth) Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (293)
Cancellation by sponsor (33)

Date

2023 (72)
2022 (18)
2021 (3)
2020 (8)
2019 (65)
2018 (78)
2017 (1)
2016 (74)
2014 (1)
2013 (4)
2012 (1)
2011 (1)

Results for "[search-keyword]"

Search

Sponsor content

326 result(s) found, displaying 71 to 80

Irinotecan Hydrochloride Injection 100 mg in 5 mL (15) (395496)

5 September 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Irinotecan Hydrochloride Injection 100 mg in 5 mL (15).
Irinotecan Hydrochloride Injection 40 mg in 2 mL (14) (395495)

5 September 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Irinotecan Hydrochloride Injection 40 mg in 2 mL (14).
Cisplatin Injection 10 mg in 10 mL (2) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Irinotecan hydrochloride injection 40 mg in 2 mL (7) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Leucovorin Calcium Injection 50 mg in 5 mL (2) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Cisplatin Injection 10 mg in 10 mL (4) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Cisplatin Injection 10 mg in 10 mL (3) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Cisplatin Injection 50 mg in 50 mL (4) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Cisplatin Injection 50 mg in 50 mL (3) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd
Cisplatin Injection 10 mg in 10 mL (1) Cancelled under Section 30(1)(c) of the Act

16 May 2023

Cancellation by sponsor

Requested by Pfizer (Perth) Pty Ltd

Pages

First page
Previous page
…
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Page 11
Page 12
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.